Transplants
New findings in transplants described from the United States, United Kingdom and Sweden
Published in Blood Weekly, September 7th, 2006
Study 1: Recent research from the United States published in the journal Liver International has chronicled the impact of pegylated interferon alpha-2B and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C virus (HCV).
"Patients with recurrent HCV are often treated with interferon-based therapy in an attempt to eradicate HCV and prevent cirrhosis requiring retransplantation. We describe our experience with pegylated interferon and ribavirin and the impact of this therapy on hepatic fibrosis," wrote S. Mukherjee and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-09-07)
More Articles from Blood Weekly
- Blood Banking
SYTO 16 dye detects apoptotic lymphocytes and CD34+ cells in cryopreserved cord blood - Blood Safety
Filter modifications reduce risk of transfusion-transmitted prion disease - Tissue Engineering
Autologous human tissue-engineered heart valves developed - Tissue Engineering
Heart valve allografts remodel and grow accordingly to somatic growth of child - Acute Myeloid Leukemia
Dacogen (decitabine) for Injection receives U.S. orphan drug designation for patients with AML - Adipose Tissue
Adipose tissue could be a good source of cells for short-term hematopoiesis reconstitution - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
